Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Braveheart Bio, Inc. - Common Stock (NQ:BRVE)

25.31 -2.13 (-7.76%)
Streaming Delayed Price Updated: 2:23 PM EDT, Aug 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 488,808
Open 27.95
Bid (Size) 25.10 (300)
Ask (Size) 25.52 (200)
Prev. Close 27.44
Today's Range 24.96 - 27.95
52wk Range 24.61 - 32.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Insiders Are Betting Big on These 3 Healthcare Stocks ↗
Insiders are buying shares of Braveheart Bio, BlossomHill Therapeutics and Elanco, three health care stocks with differing risk profiles, analyst ratings, and pipeline catalysts ahead. 
Via MarketBeat
Topics Initial Public Offering
News headline image
Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success? ↗
Option exercise expands executive's long-term equity stake to 612,251 shares, now valued at $18.37 million based on August 7 market close. 
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance

Performance

YTD
-15.1%
-15.1%
1 Month
-15.1%
-15.1%
3 Month
-15.1%
-15.1%
6 Month
-15.1%
-15.1%
1 Year
-15.1%
-15.1%

More News

Read More
News headline image
Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors? ↗
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Braveheart Bio CEO Travis Murdoch Buys 83,333 Shares for $1.5 Million. Is This a Buy Signal for Investors? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Braveheart Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Braveheart Bio, Inc. - Common Stock publicly traded?
Yes, Braveheart Bio, Inc. - Common Stock is publicly traded.
What exchange does Braveheart Bio, Inc. - Common Stock trade on?
Braveheart Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Braveheart Bio, Inc. - Common Stock?
The ticker symbol for Braveheart Bio, Inc. - Common Stock is BRVE on the Nasdaq Stock Market
What is the current price of Braveheart Bio, Inc. - Common Stock?
The current price of Braveheart Bio, Inc. - Common Stock is 25.31
When was Braveheart Bio, Inc. - Common Stock last traded?
The last trade of Braveheart Bio, Inc. - Common Stock was at 08/31/26 02:23 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.